Table 1: Descriptive statistics of demographic and clinical data at baseline visit (V1) of PsA patients (n=914)
*To evaluate improvement at week 52 participation of V6 (week 52) was mandatory. Percentage refers to all patients with a documented baseline, V2 and V6 (n=428).